Skip to main content

Orchard Therapeutics plc

ORTXDelisted Jan 24, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Orchard Therapeutics plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
−12 vs. Q4 2022
Shares held
5.81M
+1.41M (+32.2%) vs. Q4 2022Converted for a 1-for-10 split
Total value
$31.2M
+$14.9M (+91.4%) vs. Q4 2022
New holders
8
8 more added
Sold out
20
8 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 35 institutions
Q1 2021: 83 institutionsQ2 2021: 85 institutionsQ3 2021: 79 institutionsQ4 2021: 72 institutionsQ1 2022: 61 institutionsQ2 2022: 50 institutionsQ3 2022: 47 institutionsQ4 2022: 47 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 32 institutionsQ4 2023: 47 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $31.2M
Q1 2021: $546.3MQ2 2021: $350.8MQ3 2021: $167.4MQ4 2021: $84.6MQ1 2022: $38.9MQ2 2022: $30.2MQ3 2022: $24.7MQ4 2022: $16.3MQ1 2023: $31.2MQ2 2023: $26.2MQ3 2023: $46.9MQ4 2023: $122.0MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ORTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202347$122.0M
Q3 202332$46.9M
Q2 202333$26.2M
Q1 202335$31.2M
Q4 202247$16.3M
Q3 202247$24.7M
Q2 202250$30.2M
Q1 202261$38.9M
Q4 202172$84.6M
Q3 202179$167.4M
Q2 202185$350.8M
Q1 202183$546.3M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q4 2022.

Institutions holding ORTX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Federated Hermes, Inc.1,925,377$10.3M0.03%+1,085,208+129.2%AddedConverted for a 1-for-10 split
Deep Track Capital, LP1,166,670$6.27M0.27%+1,166,670New
CHI Advisors LLC785,738$4.22M1.12%−13,002−1.6%ReducedConverted for a 1-for-10 split
Temasek Holdings (Private) Ltd431,904$2.32M0.01%00.0%UnchangedConverted for a 1-for-10 split
Deerfield Management Company, L.P. (Series C)316,169$1.70M0.04%00.0%UnchangedConverted for a 1-for-10 split
Citigroup Inc167,732$900.7K0.00%+167,622+152,383.6%AddedConverted for a 1-for-10 split
Kapitalo Investimentos Ltda143,157$768.8K0.25%+143,157New
Citadel Advisors LLC123,313$662.2K0.00%−106,119−46.3%ReducedConverted for a 1-for-10 split
Acadian Asset Management LLC120,259$645.0K0.00%00.0%UnchangedConverted for a 1-for-10 split
Platinum Investment Management Ltd119,128$639.7K0.02%+119,128New
Renaissance Technologies LLC91,118$489.0K0.00%−93,110−50.5%ReducedConverted for a 1-for-10 split
Mariner, LLC86,307$463.0K0.00%+23,210+36.8%AddedConverted for a 1-for-10 split
UBS Oconnor LLC67,512$362.5K0.01%+67,512New
Tang Capital Management LLC50,000$268.5K0.04%−150,000−75.0%ReducedConverted for a 1-for-10 split
JPMorgan Chase & Co48,225$259.0K0.00%+26,508+122.1%AddedConverted for a 1-for-10 split
FMR LLC41,228$221.4K0.00%−819,910−95.2%ReducedConverted for a 1-for-10 split
Morgan Stanley30,030$161.3K0.00%+889+3.1%AddedConverted for a 1-for-10 split
Goldman Sachs Group Inc28,312$152.0K0.00%+26,290+1,300.0%AddedConverted for a 1-for-10 split
Cormorant Asset Management, LP25,664$138.0K0.01%00.0%UnchangedConverted for a 1-for-10 split
Forefront Analytics, LLC14,654$78.7K0.04%−1,835−11.1%ReducedConverted for a 1-for-10 split
Sanders Morris Harris LLC10,250$55.0K0.02%+10,250New
Woodline Partners LP10,000$53.7K0.00%+10,000New
Bank of America Corp3,785$20.3K0.00%+1,955+106.8%AddedConverted for a 1-for-10 split
Wells Fargo & Company1,250$6.71K0.00%00.0%UnchangedConverted for a 1-for-10 split
Advisor Group Holdings, Inc.711$3.82K0.00%00.0%UnchangedConverted for a 1-for-10 split
UBS Group AG380$2.04K0.00%−1,304−77.4%ReducedConverted for a 1-for-10 split
Barclays PLC200$1.07K0.00%00.0%UnchangedConverted for a 1-for-10 split
Northwestern Mutual Wealth Management Co150$8060.00%+150New
Concord Wealth Partners100$5370.00%00.0%UnchangedConverted for a 1-for-10 split
Beaird Harris Wealth Management, LLC12$650.00%00.0%UnchangedConverted for a 1-for-10 split
Mine & Arao Wealth Creation & Management, LLC.10$540.00%00.0%UnchangedConverted for a 1-for-10 split
Armstrong Advisory Group, Inc5$270.00%00.0%UnchangedConverted for a 1-for-10 split
Group One Trading, L.P.1$50.00%+1New
Royal Bank of Canada70$00.00%+69+7,677.8%AddedConverted for a 1-for-10 split
CWM, LLC83$00.00%−5−6.0%ReducedConverted for a 1-for-10 split
Artal Group S.A.0$00.00%−180,386−100.0%Sold outConverted for a 1-for-10 split
Millennium Management LLC0$00.00%−31,952−100.0%Sold outConverted for a 1-for-10 split
Jane Street Group, LLC0$00.00%−7,564−100.0%Sold outConverted for a 1-for-10 split
Allegheny Financial Group LTD0$00.00%−2,875−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Securities, LLC0$00.00%−2,536−100.0%Sold outConverted for a 1-for-10 split
Geode Capital Management, LLC0$00.00%−2,608−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Investments, LP0$00.00%−2,191−100.0%Sold outConverted for a 1-for-10 split
Banque Cantonale Vaudoise0$00.00%−2,400−100.0%Sold outConverted for a 1-for-10 split
Spears Abacus Advisors LLC0$00.00%−2,115−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Advisers, LP0$00.00%−2,110−100.0%Sold outConverted for a 1-for-10 split
StoneX Group Inc.0$00.00%−1,500−100.0%Sold outConverted for a 1-for-10 split
Holderness Investments Co0$00.00%−1,473−100.0%Sold outConverted for a 1-for-10 split
IPG Investment Advisors LLC0$00.00%−1,410−100.0%Sold outConverted for a 1-for-10 split
Oppenheimer & Co Inc0$00.00%−1,150−100.0%Sold outConverted for a 1-for-10 split
Lane Generational LLC0$00.00%−1,083−100.0%Sold outConverted for a 1-for-10 split
HighTower Advisors, LLC0$00.00%−1,200−100.0%Sold outConverted for a 1-for-10 split
Tower Research Capital LLC (TRC)0$00.00%−965−100.0%Sold outConverted for a 1-for-10 split
Virtu Financial LLC0$00.00%−1,202−100.0%Sold outConverted for a 1-for-10 split
Ironsides Asset Advisors, LLC0$00.00%−1,058−100.0%Sold outConverted for a 1-for-10 split
Connecticut Wealth Management, LLC0$00.00%−1,000−100.0%Sold outConverted for a 1-for-10 split